Published 12 days ago • loading... • Updated 12 days ago

Annovis Bio (NYSE:ANVS) Releases Earnings Results, Misses Estimates By $0.04 EPS

Summary by watchlistnews.com

Annovis Bio (NYSE:ANVS – Get Free Report) released its quarterly earnings data on Friday. The company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.39) by ($0.04), Zacks reports. Annovis Bio Price Performance Shares of ANVS traded down $0.04 on Friday, reaching $1.77. The company’s stock had a trading volume of 225,092 […]

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

ADKhabar

Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results

March 21, 2025 17:05 ET | Source: Annovis Bio Inc. MALVERN, Pa., March 21, 2025 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today provided corporate updates and fourth quarter/full […]

12 days ago

Read Full Article